Janus Henderson Group
EDIT icon

Janus Henderson Group’s Editas Medicine EDIT Stock Holding History

Janus Henderson Group’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-30,107
Closed -$103K – 2545
2024
Q3 		$103K Hold
30,107
– – ﹤0.01% 2511
2024
Q2 		$141K Sell
30,107
-420
-1% -$2.37K ﹤0.01% 2469
2024
Q1 		$226K Buy
30,527
+3
+0% +$25 ﹤0.01% 2370
2023
Q4 		$309K Sell
30,524
-65
-0.2% -$571 ﹤0.01% 2228
2023
Q3 		$239K Buy
30,589
+78
+0.3% +$669 ﹤0.01% 2293
2023
Q2 		$251K Sell
30,511
-37
-0.1% -$322 ﹤0.01% 2345
2023
Q1 		$222K Buy
30,548
+16,857
+123% +$150K ﹤0.01% 2441
2022
Q4 		$121K Sell
13,691
-13,691
-50% -$150K ﹤0.01% 2299
2022
Q3 		$334K Buy
27,382
+13,720
+100% +$214K ﹤0.01% 2145
2022
Q2 		$162K Sell
13,662
-25
-0.2% -$335 ﹤0.01% 2374
2022
Q1 		$260K Buy
+13,687
New +$254K ﹤0.01% 2307
2020
Q3 		– Sell
-157,238
Closed -$4.65M – 1329
2020
Q2 		$4.65M Buy
+157,238
New +$4.11M ﹤0.01% 924
2017
Q2 		– Sell
-50,000
Closed -$1.12M – 1312
2017
Q1 		$1.12M Buy
+50,000
New +$1.04M 0.01% 659

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Janus Henderson Group's EDIT Position: Q4 2024 in Review

Janus Henderson Group sold out of Editas Medicine (EDIT) in Q4 2024, closing a stake of 30,107 shares — an estimated $103K sold.

Janus Henderson Group first reported a position in EDIT in Q1 2017 and held it in 13 quarters. The position peaked at $4.65M in Q2 2020. 206 funds tracked by Wall St. Rank hold EDIT as of Q4 2024.

  • Janus Henderson Group reported no remaining Editas Medicine position as of Q4 2024 after selling out during the quarter.
  • Janus Henderson Group sold 30,107 Editas Medicine shares in Q4 2024, an estimated $103K.
  • Janus Henderson Group first reported a position in Editas Medicine in Q1 2017 and held it in 13 quarters.
  • Janus Henderson Group's Editas Medicine position peaked at $4.65M in Q2 2020.
  • 206 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2024.

Based on Janus Henderson Group's 13F filing for Q4 2024, filed 14 Feb 2025.